Organization · Venture Studio
NuevaBio
NuevaBio is an investment company based in Palo Alto that focuses on founding, seeding, and growing innovative biotech companies, particularly in the therapeutic areas of metabolic diseases and mitochondrial dysfunction.
Overview
What NuevaBio does
What NuevaBio is
NuevaBio is an investment company based in Palo Alto that focuses on founding, seeding, and growing innovative biotech companies, particularly in the therapeutic areas of metabolic diseases and mitochondrial dysfunction.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- April 29, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find NuevaBio elsewhere
Open the official website or a supported primary organization account.
Capability profile
NuevaBio as a funder
Investment thesis
NuevaBio focuses on founding, seeding, and growing innovative companies in the biopharmaceutical sector, particularly in therapeutics related to metabolic and mitochondrial biology.
Focus narrative
NuevaBio's investment focus is on early-stage biopharmaceutical companies, particularly those developing therapies for metabolic disorders, obesity, and mitochondrial dysfunction. The firm aims to build companies around experienced operators and differentiated drug-development programs, ensuring a strong scientific match and a clear path to company creation.
Value beyond capital
NuevaBio adds value to its portfolio companies by providing not only financial support but also strategic guidance from its experienced team. The firm's founders bring extensive knowledge in drug development, medicinal chemistry, and business strategy, facilitating the growth and success of the companies they invest in.
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B
- Regions
- United StatesNorth America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 2
Portfolio context
OrsoBio: A clinical-stage biopharmaceutical company developing treatments for obesity and related metabolic disorders. NuevaBio has participated in OrsoBio's funding rounds, including a $60M Series A and a $67M Series B. MitoPower: A biopharmaceutical company focused on therapies for disorders associated with mitochondrial dysfunction, significantly backed by NuevaBio.
Capability profile
NuevaBio as a program host
Program thesis
NuevaBio is an investment company focused on founding, seeding, and growing innovative companies in the biopharmaceutical sector, particularly in therapeutics related to metabolic diseases and mitochondrial dysfunction.
Focus narrative
NuevaBio's focus areas include the development of therapeutics for metabolic diseases, obesity, type 2 diabetes, and disorders associated with mitochondrial dysfunction. The organization aims to leverage the extensive experience of its founders to create and support companies in these specialized fields.
Value and support
NuevaBio offers significant investment support, expertise in drug development, and a network of industry connections to help founders build and grow their companies in the biopharmaceutical sector.
Additional public guidance
Q: What types of companies does NuevaBio invest in? A: NuevaBio focuses on founding and investing in biopharmaceutical companies, particularly those involved in metabolic diseases and mitochondrial health. Q: How does NuevaBio support its portfolio companies? A: NuevaBio provides funding, strategic guidance, and access to a network of industry experts to help companies grow.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B
- Regions
- United States
Alumni and track record
Alumni context
Notable alumni companies include OrsoBio, a clinical-stage biopharmaceutical company developing treatments for obesity and related metabolic disorders, and MitoPower, which develops therapies for mitochondrial dysfunction.
Common questions
What to know about NuevaBio
Upseed classifies NuevaBio under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 29, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.